Joint Replacement Institute, Saint Vincent Medical Center, Los Angeles, CA 90057, USA.
J Bone Joint Surg Am. 2010 Nov 17;92(16):2663-71. doi: 10.2106/JBJS.I.01715.
There was a need for information about the long-term performance of the modern generation of hip resurfacing implants. A retrospective review of the first 100 hips that had implantation of one resurfacing design and had been followed for a minimum of ten years was performed.
Between 1996 and 1998, 100 CONSERVE PLUS hip resurfacing devices were implanted by a single surgeon in eighty-nine patients. The mean age of the patients was 49.1 years, and fifty-nine patients were male. Primary osteoarthritis was the etiology for sixty-four hips. All patients were assessed clinically and radiographically.
The mean duration of follow-up was 11.7 years (range, 10.8 to 12.9 years). Two patients were lost to follow-up, and five patients died of causes unrelated to the surgery. Eleven hips had conversion to total hip arthroplasty because of loosening of the femoral component (eight), a femoral neck fracture (one), recurrent subluxation (one), and late infection (one). The Kaplan-Meier survivorship was 88.5% at ten years. None of the resurfacing arthroplasties failed in the twenty-eight hips that had a femoral component of >46 mm and no femoral head cystic or necrotic defects of >1 cm. Five hips had narrowing of the femoral neck, three had radiolucent zones interpreted as osteolysis, and twenty had signs of neck-socket impingement. Five hips had radiolucencies around the metaphyseal stem (two partial and three complete) that had been stable for 7.8 to 10.2 years. The mean scores on the University of California at Los Angeles (UCLA) system at the time of the latest follow-up were 9.5 points for pain, 9.3 points for walking, 8.9 points for function, and 6.8 points for activity; the mean scores on the physical and mental components of the Short Form-12 (SF-12) were 47.3 and 50.5 points, respectively; and the mean Harris hip score was 90 points.
The results of the present series constitute a reference point to which subsequent series should be compared. These ten-year results in a group of young patients are satisfactory, and the low rate of osteolysis is encouraging, but longer follow-up is required for comparison with conventional total hip arthroplasty.
需要了解现代一代髋关节表面置换植入物的长期性能。对第一批接受一种髋关节表面置换设计并随访至少 10 年的 100 例髋关节进行回顾性研究。
1996 年至 1998 年间,一位外科医生对 89 例患者的 100 例 CONSERVE PLUS 髋关节表面置换装置进行了植入。患者的平均年龄为 49.1 岁,59 例为男性。原发性骨关节炎是 64 例髋关节的病因。所有患者均进行临床和影像学评估。
平均随访时间为 11.7 年(范围 10.8 至 12.9 年)。2 例患者失访,5 例患者因与手术无关的原因死亡。11 例髋关节因股骨部件松动(8 例)、股骨颈骨折(1 例)、反复半脱位(1 例)和晚期感染(1 例)而转为全髋关节置换术。10 年时 Kaplan-Meier 生存率为 88.5%。在 28 例股骨部件>46mm 且无股骨颈囊性或坏死性缺损>1cm 的髋关节中,无髋关节表面置换术失败。5 例髋关节出现股骨颈狭窄,3 例出现放射性透亮区被认为是骨溶解,20 例出现颈部窝撞击迹象。5 例髋关节的骨干内有金属内植物周围透亮影(2 例部分,3 例完全),稳定 7.8 至 10.2 年。最新随访时,加州大学洛杉矶分校(UCLA)系统的平均评分分别为疼痛 9.5 分、行走 9.3 分、功能 8.9 分、活动 6.8 分;简短形式 12 项(SF-12)的身体和精神成分的平均评分分别为 47.3 分和 50.5 分;Harris 髋关节评分平均为 90 分。
本系列的结果构成了后续系列比较的参考点。这组年轻患者的十年结果令人满意,低骨溶解率令人鼓舞,但需要更长时间的随访才能与传统全髋关节置换术进行比较。